Influenza and pneumococcal vaccine coverage among a random sample of hospitalised persons aged 65 years or more, Victoria
DOI:
https://doi.org/10.33321/cdi.2005.29.28Keywords:
communicable diseases, disease control, influenza, pneumococcal vaccine, influenza vaccineAbstract
This study was undertaken to assess the uptake of influenza and pneumococcal vaccination based on provider records of the hospitalised elderly, a group at high risk of influenza and pneumococcal disease. The study used a random sample of 3,204 admissions at two Victorian teaching hospitals for patients, aged ≥65 years who were discharged between 1 April 2000 and 31 March 2002. Information on whether the patient had received an influenza vaccination within the year prior to admission or pneumococcal vaccination within the previous five years was ascertained from the patient's nominated medical practitioner/vaccine provider. Vaccination records were obtained from providers for 82 per cent (2,804/2,934) of eligible subjects. Influenza vaccine coverage was 70.9 per cent (95% CI 68.9–72.9), pneumococcal coverage was 52.6 per cent (95% CI 50.4–54.8) and 46.6 per cent (95% CI 44.4–48.8) had received both vaccines. Coverage for each vaccine increased seven per cent over the two study years. For pneumococcal vaccination, there was a marked increase in 1998 coinciding with the introduction of Victoria 's publicly funded program. Influenza and pneumococcal vaccine coverage in eligible hospitalised adults was similar to, but did not exceed, estimates in the general elderly population. Pneumococcal vaccination coverage reflected the availability of vaccine through Victoria 's publicly funded program. A nationally funded pneumococcal vaccination program for the elderly, as announced recently, should improve coverage. However, these data highlight the need for greater awareness of pneumococcal vaccine among practitioners and for systematic recording of vaccination status, as many of these subjects will soon become eligible for revaccination. Commun Dis Intell 2005;29:283–288.
Downloads
References
National Health and Medical Research Council. The Australian Immunisation Handbook. 8th edition. Canberra: Australian Government Department of Health and Ageing, 2003.
Australian Government Department of Health and Ageing. Commonwealth Government to provide pneumococcal vaccine for both young and old. Canberra, 2004.
Forrest JM, McIntyre PB, Burgess MA. Pneumococcal disease in Australia. Commun Dis Intell 2000; 24:89–92.
Taylor A, Wilson D, Dal Grande E, Gill T. National Influenza Survey (a population survey of vaccination uptake in Australia) October 2000. Adelaide: South Australian Department of Human Services, 2000.
Roy Morgan Research. Quantitative Research to Evaluate the Department's Influenza Vaccine Program for older Australians July 2002. Sydney: Department of Health and Aged Care, 2002.
Mac Donald R, Baken L, Nelson A, Nichol KL. Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med 1999;16:173–177.
Long CE, Kouides RW, Peer S, LaForce FM, Whitney C. Accuracy of self-report of pneumococcal vaccine status in older adults, Celebrating a century of progress in public health, Chicago, Illinois, November 7–11, 1999. American Public Health Association.
Andrews RM. Assessment of vaccine coverage following the introduction of a publicly funded pneumococcal vaccine program for the elderly in Victoria, Australia. Vaccine 2005;23:2756–2761.
Zimmerman RK, Raymund M, Janosky JE, Nowalk MP, Fine MJ. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine 2003;21:1486–1491.
StataCorp. Stata Statistical Software. College Station, Texas: Stata Corporation, 2003.
Health Insurance Commission. Pharmaceutical Benefits Schedule item statistics, item no. 1903E services by scheme and calendar year by state, January 1992 to December 2001. Vol. 2003: HIC, 2003.
Andrews RM, Lester RA. Improving pneumococcal vaccination coverage among older people in Victoria. Med J Aust 2000;173:S45–S47.
MacIntyre CR, Kainer MA, Brown GV. A randomised, clinical trial comparing the effectiveness of hospital and community-based reminder systems for increasing uptake of influenza and pneumococcal vaccine in hospitalised patients aged 65 years and over. Gerontology 2003; 49:33–40.
Andrews RM, Counahan ML, Hogg GG, McIntyre PB. Effectiveness of a publicly funded pneumococcal vaccination program against invasive pneumococcal disease among the elderly in Victoria, Australia. Vaccine 2004;23:132–138.
Sisk JE, Moskowitz AJ, Whang W, Lin JD, Fedson DS, McBean AM, et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA 1997;278:1333–1339. Erratum JAMA 2000;283:341.
Ament A, Baltussen R, Duru G, Rigaud-Bully C, de Graeve D, Ortqvist A, et al. Cost-effectiveness of pneumococcal vaccination of older people: A study in 5 western european countries. Clin Infect Dis 2000;31:444–450.
Ament A, Fedson DS, Christie P. Pneumococcal vaccination and pneumonia: even a low level of clinical effectiveness is highly cost-effective. Clin Infect Dis 2001;33:2078–2079.
Kelly H, Attia J, Andrews R, Heller RF. The number needed to vaccinate (NNV) and population extensions of the NNV: comparison of influenza and pneumococcal vaccine programmes for people aged 65 years and over. Vaccine 2004;22:2192–2198.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2005 Communicable Diseases Intelligence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
